Brian C. Stephenson's most recent trade in BridgeBio Pharma Inc was a trade of 8,500 Common Stock done at an average price of $17 . Disclosure was reported to the exchange on Feb. 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Pharma Inc | Brian C. Stephenson | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 25 Feb 2025 | 8,500 | 110,964 (0%) | 0% | 17 | 144,500 | Common Stock |
| BridgeBio Pharma Inc | Brian C. Stephenson | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2025 | 8,500 | 440,170 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Brian C. Stephenson | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 33.18 per share. | 25 Feb 2025 | 8,400 | 102,564 (0%) | 0% | 33.2 | 278,697 | Common Stock |
| BridgeBio Pharma Inc | Brian C. Stephenson | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 34.18 per share. | 25 Feb 2025 | 100 | 102,464 (0%) | 0% | 34.2 | 3,418 | Common Stock |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2025 | 25,798 | 119,714 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2025 | 17,368 | 138,947 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.90 per share. | 16 Feb 2025 | 13,102 | 106,612 (0%) | 0% | 34.9 | 457,260 | Common Stock |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2025 | 6,705 | 80,459 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | Sale of securities on an exchange or to another person at price $ 36.16 per share. | 16 Feb 2025 | 4,148 | 102,464 (0%) | 0% | 36.2 | 149,973 | Common Stock |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2025 | 946 | 2,840 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2025 | 779 | 0 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 28 Jan 2025 | 68,000 | 161,758 (0%) | 0% | 17 | 1,156,000 | Common Stock |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | Sale of securities on an exchange or to another person at price $ 36.29 per share. | 28 Jan 2025 | 68,000 | 93,758 (0%) | 0% | 36.3 | 2,467,761 | Common Stock |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2025 | 68,000 | 448,670 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 10 Dec 2024 | 42,683 | 42,683 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 19 Nov 2024 | 4,156 | 93,758 (0%) | 0% | 22.4 | 93,137 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Nov 2024 | 25,799 | 110,991 (0%) | 0% | - | Common Stock | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Nov 2024 | 17,369 | 156,315 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Nov 2024 | 13,077 | 97,914 (0%) | 0% | 23.7 | 310,186 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Nov 2024 | 6,705 | 87,164 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Nov 2024 | 947 | 3,786 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Nov 2024 | 778 | 779 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2024 | 25,797 | 102,424 (0%) | 0% | - | Common Stock | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2024 | 17,368 | 173,684 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2024 | 13,077 | 89,347 (0%) | 0% | 24.4 | 319,079 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2024 | 6,705 | 93,869 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2024 | 2,457 | 86,890 (0%) | 0% | 24.4 | 59,921 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2024 | 1,698 | 85,192 (0%) | 0% | 25.1 | 42,669 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2024 | 946 | 4,733 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2024 | 778 | 1,557 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2024 | 27,507 | 90,415 (0%) | 0% | - | Common Stock | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2024 | 17,368 | 191,052 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2024 | 13,943 | 76,472 (0%) | 0% | 31.0 | 432,791 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2024 | 6,704 | 100,574 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2024 | 1,710 | 0 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2024 | 947 | 5,679 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2024 | 778 | 2,335 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 12 Mar 2024 | 107,278 | 107,278 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 12 Mar 2024 | 15,442 | 15,442 | - | - | Stock Option (right to buy) | ||
| BridgeBio Pharma Inc | Stephenson Brian C. | Secretary, Treasurer & CFO | 16 Feb 2024 | 44,996 | 81,827 (0%) | 0% | - | Common Stock | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Feb 2024 | 24,193 | 0 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian Stephenson C. | Secretary, Treasurer & CFO | 16 Feb 2024 | 18,919 | 62,908 (0%) | 0% | 37.2 | 703,976 | Common Stock | |
| BridgeBio Pharma Inc | C. Stephenson Brian | Secretary, Treasurer & CFO | 16 Feb 2024 | 17,369 | 208,420 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | C. Stephenson Brian | Secretary, Treasurer & CFO | 16 Feb 2024 | 1,710 | 1,710 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Stephenson Brian C. | Secretary, Treasurer & CFO | 16 Feb 2024 | 946 | 6,626 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Stephenson Brian C. | Secretary, Treasurer & CFO | 16 Feb 2024 | 778 | 3,113 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2023 | 44,994 | 81,704 (0%) | 0% | - | Common Stock | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2023 | 24,193 | 48,386 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2023 | 22,683 | 36,710 (0%) | 0% | 28.6 | 648,455 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2023 | 22,311 | 59,393 (0%) | 0% | 29.8 | 664,868 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2023 | 17,368 | 243,157 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2023 | 1,709 | 5,130 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2023 | 946 | 8,519 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2023 | 778 | 4,669 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2023 | 44,996 | 81,404 (0%) | 0% | - | Common Stock | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2023 | 24,424 | 36,408 (0%) | 0% | 14.0 | 342,168 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2023 | 24,193 | 72,579 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2023 | 20,572 | 60,832 (0%) | 0% | 14.1 | 289,859 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2023 | 17,368 | 260,525 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2023 | 1,710 | 6,839 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2023 | 947 | 9,465 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 May 2023 | 778 | 5,447 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 03 May 2023 | 64,929 | 36,408 (0%) | 0% | 14.2 | 920,693 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 05 Apr 2023 | 55,500 | 101,337 (0%) | 0% | 15.5 | 857,697 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 03 Mar 2023 | 62,692 | 156,837 (0%) | 0% | 11.0 | 687,148 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Feb 2023 | 27,627 | 247,156 (0%) | 0% | - | Common Stock | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Feb 2023 | 24,193 | 96,772 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Feb 2023 | 15,567 | 221,679 (0%) | 0% | 12.7 | 196,977 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Feb 2023 | 9,910 | 237,246 (0%) | 0% | 12.6 | 125,262 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Feb 2023 | 2,150 | 219,529 (0%) | 0% | 13.1 | 28,089 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Feb 2023 | 1,710 | 8,549 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Feb 2023 | 946 | 10,412 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Feb 2023 | 778 | 6,225 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 03 Feb 2023 | 61,040 | 219,184 (0%) | 0% | 11.0 | 671,922 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 05 Jan 2023 | 61,040 | 280,224 (0%) | 0% | 7.7 | 468,470 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2022 | 26,680 | 350,487 (0%) | 0% | - | Common Stock | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2022 | 24,193 | 145,158 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2022 | 9,227 | 341,260 (0%) | 0% | 11.1 | 102,235 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2022 | 1,709 | 11,969 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 16 Aug 2022 | 778 | 7,781 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | 16 May 2022 | 26,680 | 333,035 (0%) | 0% | - | Common Stock | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | 16 May 2022 | 24,192 | 169,351 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | 16 May 2022 | 9,228 | 323,807 (0%) | 0% | 6.7 | 62,197 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | 16 May 2022 | 1,710 | 13,678 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | 16 May 2022 | 778 | 8,559 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | 16 Mar 2022 | 193,543 | 193,543 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | 16 Feb 2022 | 2,488 | 307,375 (0%) | 0% | - | Common Stock | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | 16 Feb 2022 | 1,710 | 15,388 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | 16 Feb 2022 | 1,020 | 306,355 (0%) | 0% | 8.8 | 9,017 | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | 16 Feb 2022 | 778 | 9,337 | - | - | Restricted Stock Units | ||
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 211,366 | 211,366 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Dec 2021 | 15,144 | 15,144 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 2,488 | 305,616 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 1,710 | 17,098 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.25 per share. | 16 Nov 2021 | 1,234 | 304,382 (0%) | 0% | 47.3 | 58,307 | Common Stock |
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2021 | 778 | 10,115 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 2,487 | 304,156 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 1,709 | 18,808 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.48 per share. | 16 Aug 2021 | 1,028 | 303,128 (0%) | 0% | 49.5 | 50,865 | Common Stock |
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2021 | 778 | 10,893 | - | - | Restricted Stock Units | |
| BridgeBio Pharma Inc | Brian C. Stephenson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2021 | 2,488 | 302,531 (0%) | 0% | - | Common Stock |